Control of Asthma Patients Symptomatic on Inhaled Corticosteroids
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether IPL512,602 is safe and effective for the
treatment of asthma symptoms in patients who remain symptomatic on a background therapy of
inhaled corticosteroids.